Print

Purpose

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures. - Subjects can be any gender but must be age 18 or older. - Subject is able and willing to provide informed consent and HIPAA authorization. - Subject is able and willing to meet all study requirements. - Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion Criteria

  • Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Boulder Heart
Boulder 5574991, Colorado 5417618 80303
Contact:
Katharine Adkins
303-442-2395
kathari.adkins@bch.org

More Details

Status
Recruiting
Sponsor
HemoCept Inc.

Study Contact

Katharine Adkins
303-442-2395
kathari.adkins@bch.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.